Relay Therapeutics (RLAY) EBITDA (2019 - 2026)
Relay Therapeutics (RLAY) recorded EBITDA of -$90.46 million in Q2 2026, compared with -$75.85 million a year earlier.
Powered by 
Analysis
Relay Therapeutics (RLAY) EBITDA (2019 - 2026) Analysis & Trends
On a TTM basis, Relay Therapeutics' EBITDA came in at -$308.22 million as of Jun 30, 2026; for FY2025, it came in at -$299.18 million.
- Across earlier years, EBITDA came in at -$367 million in FY2024, -$367.73 million in FY2023, -$295.15 million in FY2022 and -$360.77 million in FY2021.
- The Q2 2026 figure is the lowest quarterly EBITDA since Q3 2024.
- Per Business Quant, the preceding three quarters came in at -$78.09 million (Q1 2026), -$60.03 million (Q4 2025) and -$79.64 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Relay Therapeutics | 3.76 Bn | 3.26 Bn | - | -90.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -90.46 Mn |
| Mar 31, 2026 | -78.09 Mn |
| Dec 31, 2025 | -60.03 Mn |
| Sep 30, 2025 | -79.64 Mn |
| Jun 30, 2025 | -75.85 Mn |
| Mar 31, 2025 | -83.66 Mn |
| Dec 31, 2024 | -83.65 Mn |
| Sep 30, 2024 | -95.00 Mn |
| Jun 30, 2024 | -99.39 Mn |
| Mar 31, 2024 | -88.97 Mn |
| Dec 31, 2023 | -90.82 Mn |
| Sep 30, 2023 | -72.21 Mn |
| Jun 30, 2023 | -104.72 Mn |
| Mar 31, 2023 | -99.98 Mn |
| Dec 31, 2022 | -71.69 Mn |
| Sep 30, 2022 | -84.86 Mn |
| Jun 30, 2022 | -76.86 Mn |
| Mar 31, 2022 | -61.75 Mn |
| Dec 31, 2021 | -66.69 Mn |
| Sep 30, 2021 | -59.98 Mn |
API Access
Relay Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RLAY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RLAY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RLAY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();